Trevor Leong

University of Melbourne

Papers

1

Total Citations

25

H-Index

1

About

Trevor Leong is a leading clinical researcher in gastrointestinal oncology, with a particular focus on gastric cancer and the role of radiotherapy in its management. His work critically evaluates the evolving landscape of adjuvant therapies, challenging long-held assumptions and shaping modern treatment paradigms. Leong is best known for his influential perspective piece, "Adjuvant radiotherapy for gastric cancer—end of the road?" (2020), which has garnered over 25 citations and sparked important debate on the diminishing utility of radiation in the era of improved systemic therapies and surgical techniques. Beyond this landmark commentary, his contributions span clinical trials and translational studies that refine risk stratification and personalize treatment for patients with upper gastrointestinal malignancies. Leong’s research is characterized by a rigorous, evidence-based approach that bridges the gap between clinical practice and emerging data, making him a respected voice in the field. His work continues to guide clinicians and researchers toward more effective, less toxic strategies for gastric cancer, underscoring his impact on both current standards and future directions in oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Adjuvant radiotherapy for gastric cancer—end of the road?
25 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: University of Melbourne

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago